SPACEReports linking AstraZeneca's coronavirus vaccine to an extremely rare form of blood clot has spotlighted the symptoms of blood clots. What should you be looking out for?
A new study recently showed that what worried many people four weeks ago is now widely accepted: AstraZeneca COVID-19 vaccine can, in rare conditions, lead to a disorder characterized by dangerous blood clots.
Large clinical trial results have revealed that the AstraZeneca COVID-19 vaccine is well-tolerated and it shields from symptomatic COVID-19 injection, including severe disease or hospital confinement.
AstraZeneca announced it had reviewed more than 17 million individuals who got their COVID-19 vaccine in the EU and UK, and the result did not show any evidence of increased risks of blood clots.
Three countries namely Denmark, Norway, and Iceland temporarily suspended the administration of the AstraZeneca COVID-19 vaccine after reports of blood clot formations in some individuals who got their vaccines.